TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent. February 23, 2001